TP53 and hepatocellular carcinoma: Herein, we found that PTL combined with ATO synergistically inhibits the in vitro and in vivo proliferation activity of HCC cells through suppressing stemness and self-renewal ability and inducing mitochondria-dependent apoptosis, in which USP7-HUWE1-p53 pathway involved.